Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma

By Merin Noah M.   Kelly Kevin R.  

Pharmaceuticals, Vol. 8, Iss. 1, 2014-12 ,pp. : 1-20

MDPI

Access to resources Recommend Favorite

CIK Cells and HDAC Inhibitors in Multiple Myeloma

By Stephan David   Weiher Hans   Schmidt-Wolf Ingo G.H.  

International Journal of Molecular Sciences, Vol. 18, Iss. 5, 2017-04 ,pp. : 945-945

MDPI

Access to resources Recommend Favorite

Structure–Activity Relationship of Halophenols as a New Class of Protein Tyrosine Kinase Inhibitors

By Feng Xiu E.   Zhao Wan Yi   Ban Shu Rong   Zhao Cheng Xiao   Li Qing Shan   Lin Wen Han  

International Journal of Molecular Sciences, Vol. 12, Iss. 9, 2011-09 ,pp. : 6104-6115

MDPI

Access to resources Recommend Favorite

Anti-Angiogenic Properties of BDDPM, a Bromophenol from Marine Red Alga Rhodomela confervoides, with Multi Receptor Tyrosine Kinase Inhibition Effects

By Wang Shuaiyu   Wang Li-Jun   Jiang Bo   Wu Ning   Li Xiangqian   Liu Shaofang   Luo Jiao   Shi Dayong  

International Journal of Molecular Sciences, Vol. 16, Iss. 6, 2015-06 ,pp. : 13548-13560

MDPI

Access to resources Recommend Favorite

Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients

By Semeniuk-Wojtaś Aleksandra   Lubas Arkadiusz   Stec Rafał   Szczylik Cezary   Niemczyk Stanisław  

International Journal of Molecular Sciences, Vol. 17, Iss. 12, 2016-12 ,pp. : 2073-2073

MDPI

Access to resources Recommend Favorite